{"name": "Luminex",
 "permalink": "luminex",
 "crunchbase_url": "http://www.crunchbase.com/company/luminex",
 "homepage_url": "http://www.luminexcorp.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@luminexcorp.com",
 "phone_number": "512-219-8020",
 "description": "",
 "created_at": "Wed Jun 22 04:43:21 UTC 2011",
 "updated_at": "Wed Jun 22 04:45:35 UTC 2011",
 "overview": "\u003Cp\u003ELuminex Corporation (Luminex) develops, manufactures and sells biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The Company\u00e2\u20ac\u2122s Multi-Analyte Profiling (xMAP) technology, an open architecture, multiplexing technology, allows simultaneous analysis of up to 500 bioassays from a small sample volume, a single drop of fluid, by reading biological tests on the surface of microscopic polystyrene beads called microspheres. xMAP technology combines this miniaturized liquid array bioassay capability with small lasers, digital signal processors and software. The Company operates in two segments: the technology and strategic partnerships (TSP) segment, and the assays and related products (ARP) segment. On May 24, 2010, Luminex completed the acquisition of 100% of the interest of Bizpac (Australia) Pty. Ltd. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       37],
      "assets/images/resized/0014/0407/140407v1-max-150x150.png"],
     [[200,
       50],
      "assets/images/resized/0014/0407/140407v1-max-250x250.png"],
     [[200,
       50],
      "assets/images/resized/0014/0407/140407v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Patrick",
      "last_name": "J. Balthrop Sr.",
      "permalink": "patrick-j-balthrop-sr",
      "image": null}},
   {"is_past": false,
    "title": "CFO, Vice President, Finance and Treasurer",
    "person":
     {"first_name": "Harriss",
      "last_name": "T. Currie",
      "permalink": "harriss-t-currie",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 34000000.0,
    "price_currency_code": "USD",
    "term_code": "cash",
    "source_url": "http://phx.corporate-ir.net/phoenix.zhtml?c=79403\u0026p=irol-newsArticle\u0026ID=1576731\u0026highlight=",
    "source_description": "Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.",
    "acquired_year": 2011,
    "acquired_month": 6,
    "acquired_day": 21,
    "company":
     {"name": "EraGen Biosciences",
      "permalink": "eragen-biosciences",
      "image":
       {"available_sizes":
         [[[150,
            135],
           "assets/images/resized/0006/7929/67929v1-max-150x150.png"],
          [[160,
            145],
           "assets/images/resized/0006/7929/67929v1-max-250x250.png"],
          [[160,
            145],
           "assets/images/resized/0006/7929/67929v1-max-450x450.png"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "12212 Technology Blvd",
    "address2": "",
    "zip_code": "78727",
    "city": "Austin",
    "state_code": "TX",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:LMNX"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}